berberine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lapatinib and BBR activate Akt through upregulation of alternative signaling, which lead to chemoresistance in TNBC cell." | 1.72 | Pharmacotranscriptomic profiling of resistant triple-negative breast cancer cells treated with lapatinib and berberine shows upregulation of PI3K/Akt signaling under cytotoxic stress. ( Chen, Y; Hin Cho, C; Imani, S; Jabbarzadeh Kaboli, P; Jomhori, M; Li, M; Luo, S; Shen, J; Wu, X; Wu, Z; Xiang, S; Xiao, Z; Zhao, Y, 2022) |
| "Berberine (BBR) is a bioactive isoquinoline alkaloid with high oral safety." | 1.62 | Berberine Inhibits MDA-MB-231 Cells as an Agonist of G Protein-Coupled Estrogen Receptor 1. ( Liu, X; Qi, M; Ren, J; Wang, H; Xiang, J; Zhao, Y; Zhou, Y, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qi, M | 1 |
| Liu, X | 1 |
| Zhou, Y | 1 |
| Wang, H | 1 |
| Zhao, Y | 2 |
| Ren, J | 2 |
| Xiang, J | 1 |
| Jabbarzadeh Kaboli, P | 1 |
| Luo, S | 1 |
| Chen, Y | 1 |
| Jomhori, M | 1 |
| Imani, S | 1 |
| Xiang, S | 1 |
| Wu, Z | 1 |
| Li, M | 1 |
| Shen, J | 1 |
| Wu, X | 1 |
| Hin Cho, C | 1 |
| Xiao, Z | 1 |
| Khorshid, S | 1 |
| Montanari, M | 1 |
| Benedetti, S | 1 |
| Moroni, S | 1 |
| Aluigi, A | 1 |
| Canonico, B | 1 |
| Papa, S | 1 |
| Tiboni, M | 1 |
| Casettari, L | 1 |
| Yao, M | 1 |
| Fan, X | 1 |
| Yuan, B | 1 |
| Takagi, N | 1 |
| Liu, S | 1 |
| Han, X | 1 |
| Liu, J | 1 |
| El Khalki, L | 1 |
| Maire, V | 1 |
| Dubois, T | 1 |
| Zyad, A | 1 |
| Kim, S | 2 |
| Lee, J | 1 |
| You, D | 2 |
| Jeong, Y | 2 |
| Jeon, M | 1 |
| Yu, J | 2 |
| Kim, SW | 2 |
| Nam, SJ | 2 |
| Lee, JE | 2 |
| Lin, YS | 1 |
| Chiu, YC | 1 |
| Tsai, YH | 1 |
| Tsai, YF | 1 |
| Wang, JY | 1 |
| Tseng, LM | 1 |
| Chiu, JH | 1 |
| Tajbakhsh, A | 1 |
| Rivandi, M | 1 |
| Abedini, S | 1 |
| Pasdar, A | 1 |
| Sahebkar, A | 1 |
| Tang, JW | 1 |
| Lin, J | 1 |
1 review available for berberine and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Regulators and mechanisms of anoikis in triple-negative breast cancer (TNBC): A review.
Topics: Anoikis; Berberine; Chlorobenzoates; Female; Gene Expression Regulation, Neoplastic; Humans; Pyrans; | 2019 |
9 other studies available for berberine and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Berberine Inhibits MDA-MB-231 Cells as an Agonist of G Protein-Coupled Estrogen Receptor 1.
Topics: Alkaloids; Antineoplastic Agents; Berberine; Cell Line, Tumor; Female; Humans; Microtubule-Associate | 2021 |
Pharmacotranscriptomic profiling of resistant triple-negative breast cancer cells treated with lapatinib and berberine shows upregulation of PI3K/Akt signaling under cytotoxic stress.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Berberine; Cell Cycle; Cell Line, Tumor; C | 2022 |
A microfluidic approach to fabricate sucrose decorated liposomes with increased uptake in breast cancer cells.
Topics: Berberine; Cell Line, Tumor; Drug Delivery Systems; Humans; Liposomes; Microfluidics; Sucrose; Tripl | 2022 |
Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell.
Topics: Apoptosis; Berberine; Caspase 1; Drugs, Chinese Herbal; Female; Humans; Inflammasomes; Interleukin-1 | 2019 |
Berberine Impairs the Survival of Triple Negative Breast Cancer Cells: Cellular and Molecular Analyses.
Topics: Berberine; Cell Culture Techniques; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Female; | 2020 |
Berberine Suppresses Cell Motility Through Downregulation of TGF-β1 in Triple Negative Breast Cancer Cells.
Topics: Animals; Benzamides; Berberine; Cell Line, Tumor; Cell Movement; Databases, Factual; Dioxoles; Down- | 2018 |
Berberine down-regulates IL-8 expression through inhibition of the EGFR/MEK/ERK pathway in triple-negative breast cancer cells.
Topics: Berberine; Cell Line, Tumor; Cell Proliferation; Down-Regulation; ErbB Receptors; Female; Humans; In | 2018 |
Different mechanisms involved in the berberine-induced antiproliferation effects in triple-negative breast cancer cell lines.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Berberine; Cell Cycle; Cell Division; Cell Line | 2019 |
[Apoptosis of MDA-MB-231 cells induced by berberine alpha-hydroxy beta-decanoylethyl sulfonate].
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Berberine; Caspase 3; Caspase 9; Cell Cycle; Cell Line | 2014 |